Search

Search Constraints

You searched for: Author/Creator Offner, Fritz

Search Results

1. A five‐year follow‐up of untreated patients with chronic lymphocytic leukaemia treated with ofatumumab and chlorambucil: final analysis of the Complement 1 phase 3 trial. (31st March 2020)

2. A gene-expression profiling score for prediction of outcome in patients with follicular lymphoma: a retrospective training and validation analysis in three international cohorts. Issue 4 (April 2018)

3. A phase 2, multicenter study investigating ofatumumab and bendamustine combination in patients with untreated or relapsed CLL. Issue 9 (3rd July 2016)

4. Central nervous system relapse in patients over 80 years with diffuse large B‐cell lymphoma: an analysis of two LYSA studies. (23rd February 2018)

5. Chlorambucil plus ofatumumab versus chlorambucil alone in previously untreated patients with chronic lymphocytic leukaemia (COMPLEMENT 1): a randomised, multicentre, open-label phase 3 trial. Issue 9980 (9th May 2015)

7. Combining Ixazomib With Subcutaneous Rituximab and Dexamethasone in Relapsed or Refractory Waldenström's Macroglobulinemia: Final Analysis of the Phase I/II HOVON124/ECWM-R2 Study. Issue 1 (1st January 2022)

8. Cusatuzumab for treatment of CD70‐positive relapsed or refractory cutaneous T‐cell lymphoma. Issue 5 (2nd November 2021)

9. Diagnosis and follow-up of monoclonal gammopathies of undetermined significance; information for referring physicians. (September 2013)

10. Health-related quality of life and patient-reported outcomes of ofatumumab plus chlorambucil versus chlorambucil monotherapy in the COMPLEMENT 1 trial of patients with previously untreated CLL. (2nd October 2016)